Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.

about

Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.

Item

http://www.wikidata.org/entity/Q38873753

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Differential expression and al ...... n imatinib-treated K562 cells.

@en

type

Item

label

Differential expression and al ...... n imatinib-treated K562 cells.

@en

prefLabel

Differential expression and al ...... n imatinib-treated K562 cells.

@en

P1476

Differential expression and al ...... n imatinib-treated K562 cells.

@en

P2093

Bo Huang

http://www.w3.org/2001/XMLSchema#string

Jin Lin

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Lin-Feng Huang

http://www.w3.org/2001/XMLSchema#string

Qing-Hua Min

http://www.w3.org/2001/XMLSchema#string

Wei-Ming Yang

http://www.w3.org/2001/XMLSchema#string

Xiao-Zhong Wang

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

SON controls cell-cycle progression by coordinated regulation of RNA splicing

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Cyclin-dependent kinases: engines, clocks, and microprocessors

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development.

Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture.

Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.

Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status.

Complexities in the development of cyclin-dependent kinase inhibitor drugs.

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

P2888

s13277-015-3493-0

P304

8127-8136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3493-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276922504

http://www.w3.org/2001/XMLSchema#string

P6179

1005882740

http://www.w3.org/2001/XMLSchema#string

P698

25983000

http://www.w3.org/2001/XMLSchema#string